Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:activeIngredient |
gptkb:live_attenuated_Vibrio_cholerae_O1
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States gptkb:FDA 2016 |
| gptkbp:ATCCode |
J07AE02
|
| gptkbp:contraindication |
severe allergic reaction to any component
|
| gptkbp:form |
oral suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxchora
|
| gptkbp:indication |
adults and children 2 through 64 years of age
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Emergent_BioSolutions
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:protectionDuration |
at least 3 months
|
| gptkbp:protectionOnset |
10 days after vaccination
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:usedFor |
prevention of cholera
|
| gptkbp:website |
https://www.vaxchora.com/
|
| gptkbp:bfsParent |
gptkb:Emergent_BioSolutions
|
| gptkbp:bfsLayer |
5
|